<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02454790</url>
  </required_header>
  <id_info>
    <org_study_id>SFP OES</org_study_id>
    <nct_id>NCT02454790</nct_id>
  </id_info>
  <brief_title>Standard Follow-Up Program (SFP) for Patients With Esophageal Cancer</brief_title>
  <acronym>SFP OES</acronym>
  <official_title>Standard Follow-up Program (SFP) for Esophageal Cancer Patients Treated With Radiotherapy or Chemoradiation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Groningen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Motive:

      In order to improve the treatment technique, a comprehensive follow-up program is needed to
      obtain all relevant patient, treatment and toxicity data from esophageal cancer patients.

      Goal:

      To set-up and maintain a database containing treatment results in terms of tumor control,
      side effects, complications and patient-reported quality of life.

      A standard database of patients receiving photon treatment will be created. These data are
      then linked to dose-volume data of radiotherapy, with the aim to build prediction models for
      both tumor control and toxicity after radio (chemo) therapy that can later be used for
      selecting patients for proton treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">January 2028</completion_date>
  <primary_completion_date type="Anticipated">January 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Acute toxicity</measure>
    <time_frame>Highest during and within 2 weeks after last day of radiation therapy</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Late toxicity</measure>
    <time_frame>Highest within one year after last day of radiation therapy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>At 1,2,3,4 and 5 years after first day of radiation therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Loco-regional tumor control</measure>
    <time_frame>At 1,2,3,4 and 5 years after first day of radiation therapy</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient-rated symptoms and Quality-of-Life</measure>
    <time_frame>Before first day of radiation therapy and at 3,6,12,24,36,48,60 months after first day of radiation therapy</time_frame>
  </other_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Esophageal Cancer</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiotherapy</intervention_name>
    <other_name>Chemoradiation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with esophageal cancer receiving a radiotherapy dose &gt; 40 Gy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with esophageal cancer

          -  Patients receiving a radiotherapy dose &gt; 40 Gy

        Exclusion Criteria:

          -  Failure to comply with any of the inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>CT Muijs, MD PhD</last_name>
    <phone>+31503615179</phone>
    <email>c.t.muijs@umcg.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700RB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CT Muijs, MD PhD</last_name>
      <phone>+31503615179</phone>
      <email>c.t.muijs@umcg.nl</email>
    </contact>
    <investigator>
      <last_name>CT Muijs, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2015</study_first_submitted>
  <study_first_submitted_qc>May 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2015</study_first_posted>
  <last_update_submitted>September 7, 2017</last_update_submitted>
  <last_update_submitted_qc>September 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Groningen</investigator_affiliation>
    <investigator_full_name>C.T. Muijs</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Acute toxicity</keyword>
  <keyword>Late toxicity</keyword>
  <keyword>Prediction models</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

